Axsome Therapeutics (AXSM) Stock Highlights

96.18 | +4.62%

2025-01-22 02:21:58

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.

Statistics

Range Today

91.95 98.5

Volume Today 1.05M

Range 1 Year

64.11 105

Volume 1 Year 158.68M

Range 3 Year

20.63 105

Volume 3 Year 693.37M

Range 10 Year

1.94 109.94

Volume 10 Year 1.53B

Highlights

Market Capitalization 4.54B (mid)

Floating Shares 36.12M

Current Price 96.18

Price To Earnings -14.58

Price To Revenue 12.77

Price To Book 47.93

Earnings Per Share -6.45

Payout Ratio 0%

Performance

Latest +4.62%

1 Month +6.87%

3 Months +3.31%

6 Months +11.29%

1 Year +12.1%

3 Years +273.37%

5 Years +6.77%

10 Years +968.67%

Benchmarks

Market Capitalization

44 / 368

Gross Profits

66 / 278

Total Revenue

54 / 300

Total Rank

209 / 368

Free Cashflow

250 / 352

Performance 5 years

115 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.